We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Infectious Diseases – News and Features

News

Nobel Laureate will Discuss Protein Power

Australian scientists will have a rare opportunity to learn about the future of biomedicine when Nobel Laureate Professor Robert Huber visits Brisbane.
News

New RNAi Tools Enable Systematic Studies of Gene Function

A unique public-private partnership led by researchers at the Broad Institute of MIT and Harvard creates RNAi-based inhibitors for nearly every human and mouse gene.
News

RNA Interference Knocks Down Prion Genes in Livestock

The strategy might be used to protect animals against influenza or foot-and-mouth disease.
News

Tecan Boosts RNA Work in France

Tecan's Freedom EVO® Workstation has been used to develop automated in vitro selection techniques for identifying and isolating aptamers.
News

eGene will be Granted Chinese Patent for DNA Analyzer Technology

Company has been granted a patent for "Optical detection in a multi-channel bio-separation system."
News

CytoGenix Enters into Supply Agreement with GE Healthcare

GE will provide CytoGenix with DNA production reagents for use in the manufacture of vaccines and therapeutic compounds by CytoGenix.
News

BioForce Completes $6 Million Private Placement

This funding will facilitate continued development of the company's pipeline technologies.
News

Bourne Research Launches Report Series Covering BioMEMS and Nanotechnology in Medicine

The Bourne Report offers the insightful market analysis available on the emerging use of MEMS and Nanotechnology in medicine.
News

Alnylam Research on miRNAs Featured in The New England Journal of Medicine

The article titled 'MicroRNAs as Therapeutic Targets' discusses clinical applications for intervening with microRNAs.
News

Nastech Presents In Vitro and In Vivo Results with its RNAi Therapeutics Program for Influenza

Nastech believe that targeting the conserved regions could enable a siRNA therapeutic to be effective against both current and future strains of the influenza virus.
Advertisement